Skip to main content
. 2020 Nov 25;14(1):100959. doi: 10.1016/j.tranon.2020.100959

Fig. 3.

Fig 3

Correlations between CTCs count and clinical features of breast cancer patients. (A) The distribution of CTC in 129 breast cancer patients and 50 healthy was detected by microfluidic chip. (B) The quantity of CTCS in three transfer states (**) indicates P < 0.05. (C) The pathological type distribution of CTC in breast cancer patients. Each data point represents the participant's CTC count, while a black horizontal line represents the group median. (*, ** means P < 0.05). (D) CTCs enumeration was associated with the molecular subtyping of breast cancer patients. (E) Changes in the number of CTCs before and after surgery. (F) Changes in the number of CTCs during two treatment.